| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Moderna, Inc. | General Counsel and Secretary | Common Stock | 901 | $93,614 | $103.90 | 27 May 2021 | Direct |
| Moderna, Inc. | General Counsel and Secretary | Stock Option (Right to Buy) | 328,352 | 27 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 27 May 2021 | 3 | -$1,051,710 | 4 | General Counsel and Secretary | 28 May 2021, 08:45 |
| MRNA | Moderna, Inc. | 25 May 2021 | 3 | -$1,001,418 | 4 | General Counsel and Secretary | 27 May 2021, 16:04 |
| MRNA | Moderna, Inc. | 20 May 2021 | 3 | -$957,462 | 4 | General Counsel and Secretary | 21 May 2021, 16:23 |
| MRNA | Moderna, Inc. | 18 May 2021 | 3 | -$959,046 | 4 | General Counsel and Secretary | 20 May 2021, 17:07 |
| MRNA | Moderna, Inc. | 13 May 2021 | 3 | -$909,150 | 4 | General Counsel and Secretary | 14 May 2021, 16:04 |
| MRNA | Moderna, Inc. | 11 May 2021 | 5 | -$898,022 | 4 | General Counsel and Secretary | 13 May 2021, 16:05 |
| MRNA | Moderna, Inc. | 06 May 2021 | 3 | -$837,474 | 4 | General Counsel and Secretary | 07 May 2021, 16:09 |